News
FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.
A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone," but experts say concerns ...
Lawmakers may have had Ivermectin in mind when they passed a law to safeguard doctors who prescribe off-label. But a judge on ...
Four states petitioned the Food and Drug Administration on Thursday to lift its lingering restrictions on abortion pills. The attorneys general of California, Massachusetts, New Jersey and New ...
In April through June of 2022, just 5 percent of abortions involved remote appointments and prescriptions. From there, we saw ...
Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.
Family planning providers are less available in many states, and health insurance coverage of Plan B and certain IUDs is ...
The same group of abortion-rights advocates whose legal challenges have stymied past attempts to stop or limit abortion in ...
A growing body of research demonstrating the safety and effectiveness of self-managed abortion with pills, coupled with the ...
Plaintiffs argued the statute would indirectly ban abortion medications by threatening providers with disciplinary action for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results